Summit Investment Advisors »

Aerovate Therapeutics shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $18k 772 22.63
2023-09-30 $11k 772 13.57
2023-06-30 $13k 772 17.15
2023-03-31 $16k 772 20.17
2022-12-31 $18k 772 23.10
2022-09-30 $12k 772 15.54
2022-06-30 $12k 772 15.54
2022-03-31 $14k 772 18.13
2021-12-31 $9.0k 772 11.66
2021-09-30 $16k 772 20.73